Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
9.87
-0.12 (-1.20%)
Jan 28, 2026, 12:13 PM EST - Market open
Immatics Market Cap
Immatics has a market cap or net worth of $1.32 billion as of January 28, 2026. Its market cap has increased by 72.41% in one year.
Market Cap
1.32B
Enterprise Value
853.02M
1-Year Change
72.41%
Ranking
Category
Stock Price
$9.87
Market Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.32B, an increase of 667.08%. That is a compound annual growth rate of 33.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 1.34B | -4.86% |
| Dec 31, 2025 | 1.41B | 65.88% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharming Group | 1.35B |
| Inventiva | 1.34B |
| AnaptysBio | 1.33B |
| Trevi Therapeutics | 1.29B |
| Sana Biotechnology | 1.29B |
| Relay Therapeutics | 1.29B |
| Rapport Therapeutics | 1.28B |
| Taysha Gene Therapies | 1.26B |